Specificity: CD45R, also designated as CD45 and PTPRC, has been identified as a transmembrane glycoprotein broadly expressed among hematopoietic cells. This antibody to CD45 is useful in differential diagnosis of lymphoid tumors from non-hematopoietic undifferentiated neoplasms. Immunogen: Isolated neoplastic cells from T-cell lymphoma